Pneumococcal polysaccharide vaccine
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

superseded


Prevention of pneumococcal disease among infants and children: use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Pneumococcal polysaccharide vaccine
  • Published Date:

    February 10, 1989

  • Source:
    MMWR. Morbidity and mortality weekly report. 1989; 38(5):64-8, 73-6.
  • Language:
    English
Filetype[HTM]


This is an HTML document so it cannot be previewed.
To open, click the "View" button.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.

You May Also Like:

  1. Personal Author:
    Levine, Orin S. ; Schwartz, Benjamin ; ...
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices. ; Centers for Disease Control and Prevention (U.S.) ; ...
    Published Date:
    October 6, 2000
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 49, no. RR-9 PMID:11055835:MODS 11055835
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use ...
    File Type:
    Filetype[PDF - 317.21 KB]
    File Type:
    Filetype[PDF - 317.21 KB]
  2. Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Published Date:
    10/06/2000
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2000; 49(RR-9):1-35.
    Description:
    In February 2000, a 7-valent pneumococcal polysaccharide-protein conjugate vaccine (Prevnar, marketed by Wyeth Lederle Vaccines) was licensed for use ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 317.21 KB]
    File Type:
    Filetype[PDF - 317.21 KB]
  3. Personal Author:
    Rodenburg, Gerwin D. ; de Greeff, Sabine C. ; ...
    Published Date:
    May 2010
    Source:
    Emerg Infect Dis. 16(5):816-823.
    Description:
    In the Netherlands, the 7-valent pneumococcal conjugate vaccine (PCV-7) was implemented in a 3+1-dose schedule in the national immunization program fo...
    File Type:
    Filetype[PDF - 271.87 KB]
    File Type:
    Filetype[PDF - 271.87 KB]
  4. Personal Author:
    Nelson, George E. ; Gershman, Kenneth A. ; ...
    Published Date:
    Feb 2012
    Source:
    Emerg Infect Dis. 18(2):208-216.
    Description:
    Pneumococcal pneumonia was a complication during previous influenza pandemics but was not evident initially during pandemic (H1N1) 2009. During Octobe...
    File Type:
    Filetype[PDF - 366.74 KB]
    File Type:
    Filetype[PDF - 366.74 KB]
  5. Personal Author:
    Davidson, Michael ; Chamblee, Carol ; ...
    Published Date:
    1993 Jul-Aug
    Source:
    Public Health Rep. 108(4):439-446
    Description:
    In response to an increasing prevalence of serious pneumococcal disease among adult Alaska Natives of northwest Alaska, a 3-year program was begun in ...
    File Type:
    Filetype[PDF - 1.35 MB]
    File Type:
    Filetype[PDF - 1.35 MB]